pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Baseline characteristics of included patients with hypercalcemia

Total (n= 123)Mild (n=69)Moderate-severe (n=54)p-value
Number of cases17710374

Sex, male79 (64.2)44 (63.8)35 (64.8)0.904

Age
 <65 years65 (52.8)35 (50.7)30 (55.6)0.594
 ≥65 years58 (47.2)34 (49.3)24 (44.4)

GFR, ml/min/1.73 m2
 ≥3090 (73.2)46 (66.7)44 (81.5)0.066
 <3033 (26.8)23 (33.3)10 (18.5)

Cancer type
 Breast17 (13.8)10 (14.5)7 (13.0)0.882
 Lung29 (23.6)17 (24.6)12 (22.2)
 Kidney5 (4.1)2 (2.9)3 (5.6)
 Others72 (58.5)40 (58.0)32 (59.2)

Cancer stage
 114 (11.4)12 (17.4)2 (3.7)0.057
 22 (1.6)1 (1.4)1 (1.9)
 32 (1.6)2 (2.9)0 (0)
 4105 (85.4)54 (78.3)51 (94.4)

Bone metastasis41 (33.3)22 (31.9)19 (35.2)0.700

Hypercalcemia history42 (34.1)22 (31.9)20 (37.0)0.550
Korean J Clin Pharm 2019;29:166-72 https://doi.org/10.24304/kjcp.2019.29.3.166
© 2019 Korean J Clin Pharm